Apolipoprotein A-I Agonists And Their Use To Treat Dyslipidemic Disorders

Details for Australian Patent Application No. 2002300463 (hide)

Owner Dasseux, J. Sekul, R. Buttner, K. Cornut, I. Metz, G.

Inventors Cornut, Isabelle; Buttner, Klaus; Dasseux, Jean-Louis; Metz, Gunther; Sekul, Renate

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002300463

Parent 747823

Filing date 26 July 2002

Wipo publication date 12 June 2003

Acceptance publication date 24 August 2006

International Classifications

C07K 14/775 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

12 June 2003 Application Open to Public Inspection

  Published as AU-B-2002300463

24 August 2006 Application Accepted

  Published as AU-B-2002300463

21 December 2006 Standard Patent Sealed

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300464-Apoliprotein A-I Agonist And Their Use To Treat Dyslipidemic Disorders

2002300462-Hygromycin a Derivatives